What is the Impact Factor of Progress in Tumor Research?

The journal Progress in Tumor Research is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Progress in Tumor Research indexed in Web of Science or Scopus?

Yes, Progress in Tumor Research is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of N/A (Q1) and an H-index of 6.

Who publishes Progress in Tumor Research and what is the Article Processing Charge (APC)?

Progress in Tumor Research is published by Karger. For exact article processing charges and subscription guidelines, consult the official editorial guidelines.

What is the ISO-4 abbreviation and acronym of Progress in Tumor Research?

The official ISO-4 abbreviation of Progress in Tumor Research is "PROG TUMOR RES". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Subscription

Progress in Tumor Research

Abbreviation (ISO):PROG TUMOR RES

•

Identifier (ISSN):0079-6263(Print)

•

Publisher:Karger

Clarivate JCR Index Advisory: Name Changed (Not Indexed in Latest JCR)

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend (2023–2025)

Clarivate IF trend for Progress in Tumor Research

WoS Q1

Annual Impact Factor Metric

Current (2025):0

Scopus SJR & Rank

N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data

H-Index (2021)

6 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessSubscription

18articles/year

0% Gold OA•0% Original Research

Aims & Scope

The scientific book series 'Progress in Tumor Research' aims to provide in depth information about important developments in cancer research. The individual volumes are authored and edited by experts to provide detailed coverage of topics selected as either representing controversial issues or belonging to areas where the speed of developments necessitates the kind of assistance offered by integrative, critical reviews.

Topics Covered (Recognized by AI)

Biology89.8%Medicine74.1%Genetics65.7%Chemistry58.3%Internal medicine53.7%Biochemistry51.9%Gene33.3%Cancer33.3%Cancer research32.4%Cell biology22.2%Pathology21.3%

Primary Research Areas

Oncology

Official Website NLM PubMed Catalog

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

8 year

2025Latest

IF0

Articles / Year—

Total Citations—

2024

IF1.727

Articles / Year—

Total Citations—

2023

IF1.524

Articles / Year—

Total Citations—

2008

IF—

Articles / Year18

Total Citations39

2007

IF—

Articles / Year13

Total Citations195

Year	Impact Factor	Articles / Year	Total Citations
2025	0	—	—
2024	1.727	—	—
2023	1.524	—	—
2008	—	18	39
2007	—	13	195
2005	—	17	364
2003	—	17	589
1999	—	30	242

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Progress in Tumor Research (abbr: PROG TUMOR RES, ISSN: 0079-6263) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Karger in Switzerland. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, an H-index of 6.

The journal enforces rigorous peer evaluation with an annual output of approximately 18 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.